Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 206 Colonic Neoplasms 89 Rectal Neoplasms 88 Stomach Neoplasms 57 Pancreatic Neoplasms 49 Neoplasms 42 Esophageal Neoplasms 42 Neoplasm Metastasis 39 Unspecified Adult Solid Tumor, Protocol Specific 30 Lung Neoplasms 28 Glioblastoma 27 Brain Neoplasms 26 Carcinoma, Non-Small-Cell Lung 24 Central Nervous System Neoplasms 23 Glioma 22 Small Cell Lung Carcinoma 21 Neuroblastoma 20 Astrocytoma 18 Adenocarcinoma Of Esophagus 18 Esophageal Squamous Cell Carcinoma 17 Gliosarcoma 16 Breast Neoplasms 15 Rhabdomyosarcoma 13 Oligodendroglioma 12 Sarcoma 11 Adenocarcinoma 10 Medulloblastoma 9 Carcinoma, Hepatocellular 9 Sarcoma, Ewing 8 Gastrointestinal Neoplasms 8

Interventions

adavosertib 3 Paclitaxel 3 olaparib 2 durvalumab 2 Fluorouracil 2 Carboplatin 2 danvatirsen 1 capivasertib 1 Pantoprazole 1 Leucovorin 1 Irinotecan 1 Injections 1 Gemcitabine 1 Doxorubicin 1 Cisplatin 1 AZD0156 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Solid Tumours × Irinotecan × Clear all

NCT02588105 2022-09-19

AToM

AstraZeneca

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon ⚡